Search Results - "Biral, E"

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia by Frugnoli, I, Cappelli, B, Chiesa, R, Biral, E, Noè, A, Evangelio, C, Fossati, M, Napolitano, S, Ciceri, F, Roncarolo, M G, Marktel, S

“…Mixed chimerism (MC) and secondary graft failure are frequent events following SCT for thalassemia. There is limited information regarding the outcome of donor…”
Get full text

Multiple BM harvests in pediatric donors for thalassemic siblings: safety, efficacy and ethical issues by Biral, E, Chiesa, R, Cappelli, B, Roccia, T, Frugnoli, I, Noè, A, Soliman, C, Fiori, R, Cursi, L, Cattaneo, F, Evangelio, C, Miniero, R, Ciceri, F, Roncarolo, M G, Marktel, S

“…Allogeneic BMT represents the only chance of cure for β-thalassemia. Occasionally, two affected individuals from the same family share a matched healthy…”
Get full text

Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia by Serafini, Giorgia, Andreani, Marco, Testi, Manuela, Battarra, MariaRosa, Bontadini, Andrea, Biral, Eika, Fleischhauer, Katharina, Marktel, Sarah, Lucarelli, Guido, Roncarolo, Maria Grazia, Bacchetta, Rosa

“…1 Mediterranean Institute of Hematology (IME Foundation), Policlinico di Tor Vergata, Rome 2 San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET),…”
Get full text

Bone marrow as a source of hematopoietic stem cells for human gene therapy of β-thalassemia by Frittoli, Marta Claudia, Biral, Erika, Cappelli, Barbara, Zambelli, Matilde, Roncarolo, Maria Grazia, Ferrari, Giuliana, Ciceri, Fabio, Marktel, Sarah

“…β-Thalassemia is a severe inherited anemia caused by insufficient production of β-globin chains. Allogeneic hematopoietic stem cell (HSC) transplantation is…”
Get more information

Optimal thalassaemia-free survival and minimal regimen-related toxicity in 50 consecutive high-risk beta thalassaemia paediatric patients using myeloablative therapy with intravenous busulphan by Chiesa, R, Cappelli, B, Crocchiolo, R, Biral, E, Noe, A, Frugnoli, I, Roccia, T, Evangelio, C, Fossati, M, Ciceri, F, Roncarolo, M.G, Marktel, S

“…Busulfan(Bu), associated with Cyclophosphamide(Cy), is part of standard conditioning regimen prior to stem cell transplantation(SCT) in beta…”
Get full text

Cyclosporine neurotoxicity in beta-thalassaemic children undergoing myeloablative BMT by Noe, A, Marktel, S, Chiesa, R, Evangelio, C, Frugnoli, I, Fossati, M, Biral, E, Napolitano, S, Ferrua, F, Biffi, A, Roccia, T, Rocarolo, M.G, Ciceri, F, Cappelli, B

“…Severe neurotoxicity (tremors, insomnia, agitation, headache, hallucinations, seizures, cortical blindness, aphasia and ataxia) is a recognized complication of…”
Get full text

Mycobacterium tuberculosis pneumonia and bacteremia after allogeneic hematopoietic stem cell transplant: report of an instructive pediatric case by Biral, Erika, Faraci, Maura, Lanino, Edoardo, Morreale, Giuseppe, Giardino, Stefano, Moroni, Cristina, Losurdo, Giuseppe, Magnano, Gian Michele, Senno, Evelina, Castagnola, Elio

“…Pulmonary infections often complicate hematopoietic stem cell transplantation (HSCT) outcome. Uncommon aetiologies, like Mycobacterium tuberculosis, should be…”
Get full text

Escalating doses of donor lymphocytes to rescue from rejection following bone marrow transplantation for thalassaemia by Frugnoli, I, Cappelli, B, Chiesa, R, Noe, A, Biral, E, Gattillo, S, Roccia, T, Evangelio, C, Fossati, M, Napolitano, S, Giardelli, A, Soliman, C, Ciceri, F, Roncarolo, M.G, Marktel, S

“…Mixed chimerism (MC) and secondary graft failure are frequent events following BMT for thalassemia. There is limited information regarding the outcome of donor…”
Get full text

Management of platelets transfusions in highly immunised beta thalassaemia children undergoing bone marrow transplantation by Napolitano, S, Zino, E, Chiesa, R, Cappelli, B, Crocchiolo, R, Biral, E, Noe, A, Frugnoli, I, Roccia, T, Evangelio, C, Fossati, M, Polselli, A, Barzizza, L, Rossini, S, Ciceri, F, Ronchi, P, Roncarolo, M.G, Fleischhauer, S, Marktel, S

“…Between 2005 and 2008, 47 thalassemia patients from middle east countries received a Bu-Cy based myeloablative BMT in our unit. During the aplasia post BMT, we…”
Get full text

Compression resistance of amalgams obtained with a new type of amalgamator by Fichman, D M, Guidi, D, Biral, E M

Get more information